Trial Profile
Investigation of efficacy and safety of basal supported oral therapy by alternate-day insulin degludec injection
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms JUN-SIBA
- 25 May 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record.
- 20 Jun 2013 New trial record